The RIFF Study (Cohort B): A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Lebrikizumab in Combination with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

被引：0

作者：

Maher, T. M. ^{[1
,2
]}

Kondoh, Y. ^{[3
]}

Corte, T. J. ^{[4
]}

Glassberg, M. K. ^{[5
]}

Costabel, U. ^{[6
]}

Lancaster, L. H. ^{[7
]}

Kardatzke, D. ^{[8
]}

Kaminski, J. ^{[9
]}

Howard, M. ^{[10
]}

Olsson, J. K. ^{[8
]}

Neighbors, M. ^{[8
]}

Owen, R. ^{[8
]}

Belloni, P. ^{[8
]}

机构：

[1] Royal Brompton Hosp, London, England

[2] Imperial Coll London, London, England

[3] Tosei Gen Hosp, Seto, Aichi, Japan

[4] Univ Sydney, Royal Prince Alfred Hosp, Sydney, NSW, Australia

[5] Univ Miami Hlth Syst, Miami, FL USA

[6] Univ Duisburg Essen, Ruhrlandklin, Essen, Germany

[7] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[8] Genentech Inc, San Francisco, CA 94080 USA

[9] Roche Prod Ltd, Welwyn Garden City, Herts, England

[10] PRO Unltd Inc, Vancouver, BC, Canada

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 197卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A6168

引用

页数：2

共 50 条

[1] The RIFF Study (Cohort A): A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Lebrikizumab as Monotherapy in Patients with Idiopathic Pulmonary Fibrosis
Swigris, J. J.
Ogura, T.
Scholand, M.
Glaspole, I.
Maher, T. M.
Kardatzke, D.
Kaminski, J.
Castro, M.
Owen, R.
Neighbors, M.
Belloni, P.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[2] LEBRIKIZUMAB IDIOPATHIC PULMONARY FIBROSIS TRIAL: A PHASE II RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO ASSESS EFFICACY AND SAFETY (RIFF)
Scalori, A.
Belloni, P.
Ackrill, A.
Kapugampola, L.
Doyle, R.
Kaminski, J.
RESPIROLOGY, 2014, 19 : 145 - 145
[3] Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis
Azuma, A
Nukiwa, T
Tsuboi, E
Suga, M
Abe, S
Nakata, K
Taguchi, Y
Nagai, S
Itoh, H
Ohi, M
Sato, A
Kudoh, S
Raghu, G
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (09) : 1040 - 1047
[4] Double-Blind, Placebo-Controlled, Randomized Trial Of Pirfenidone In Chinese Idiopathic Pulmonary Fibrosis Patients
Huang, H.
Xu, Z.
Kang, J.
Dai, H.
Chen, B.
Sun, T.
Cao, J.
Feng, R.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
[5] The Ascend Study: A Randomized, Double-Blind, Placebo Controlled Trial Of Pirfenidone In Patients With Idiopathic Pulmonary Fibrosis (ipf)
King, T. E.
Bradford, W. Z.
Castro-Bernadini, S.
Fagan, E. A.
Glaspole, I.
Glassberg, M. K.
Gorina, E.
Hopkins, P. M.
Kardatzke, D.
Lancaster, L.
Lederer, D. J.
Nathan, S. D.
Pereira, C. A.
Sahn, S. A.
Sussman, R.
Swigris, J. J.
Noble, P. W.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
[6] A Phase 2, double-blind, placebo-controlled study of N-acetylcysteine in combination in combination with pirfenidone in patients with idiopathic pulmonary fibrosis
Behr, Jurgen
Bendstrup, Elisabeth
Crestani, Bruno
Gunther, Andreas
Olschewski, Horst
Skoeld, Magnus
Wells, Athol
Wuyts, Wim
Tang, Helen
Beck, Jurgen
Albera, Carlo
EUROPEAN RESPIRATORY JOURNAL, 2014, 44
[7] Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial
Behr, Juergen
Bendstrup, Elisabeth
Crestani, Bruno
Guenther, Andreas
Olschewski, Horst
Skoeld, C. Magnus
Wells, Athol
Wuyts, Wim
Koschel, Dirk
Kreuter, Michael
Wallaert, Benoit
Lin, Chin-Yu
Beck, Juergen
Albera, Carlo
LANCET RESPIRATORY MEDICINE, 2016, 4 (06): : 445 - 453
[8] Double-Blind Randomized Trial of Pirfenidone in Chinese Idiopathic Pulmonary Fibrosis Patients
Huang, Hui
Dai, Hua Ping
Kang, Jian
Chen, Bao Yuan
Sun, Tie Ying
Xu, Zuo Jun
MEDICINE, 2015, 94 (42) : e1600
[9] The CAPACITY (CAP) Trials: Randomized, Double-Blind, Placebo-Controlled, Phase III Trials of Pirfenidone (PFD) in Patients with Idiopathic Pulmonary Fibrosis (IPF)
Noble, P.
Albera, C.
Bradford, W.
Costabel, U.
Kardatzke, D.
King, T., Jr.
Sahn, S.
Szwarcberg, J.
Valeyre, D.
du Bois, R.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
[10] Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis A Randomized, Double-Blind Placebo-controlled Trial
Kondoh, Yasuhiro
Azuma, Arata
Inoue, Yoshikazu
Ogura, Takashi
Sakamoto, Susumu
Tsushima, Kenji
Johkoh, Takeshi
Fujimoto, Kiminori
Ichikado, Kazuya
Matsuzawa, Yasuo
Saito, Takefumi
Kishi, Kazuma
Tomii, Keisuke
Sakamoto, Noriho
Aoshima, Masahiro
Araya, Jun
Izumi, Shinyu
Arita, Machiko
Abe, Mitsuhiro
Yamauchi, Hiroyoshi
Shindoh, Joe
Suda, Takafumi
Okamoto, Masaki
Ebina, Masahito
Yamada, Yoshihito
Tohda, Yuji
Kawamura, Tetsuji
Taguchi, Yoshio
Ishii, Hiroshi
Hashimoto, Naozumi
Abe, Shinji
Taniguchi, Hiroyuki
Tagawa, Jun
Bessho, Koji
Yamamori, Natsuki
Homma, Sakae
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201 (09) : 1110 - 1119

← 1 2 3 4 5 →